Belvedere Trading
CTSO icon

Belvedere Trading’s Cytosorbents Corp CTSO Stock Holding History

Belvedere Trading’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,668
Closed -$36K – 902
2023
Q1 		$36K Buy
+10,668
New +$32K ﹤0.01% 638

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Belvedere Trading's CTSO Position: Q2 2023 in Review

Belvedere Trading sold out of Cytosorbents Corp (CTSO) in Q2 2023, closing a stake of 10,668 shares — an estimated $36K sold.

Belvedere Trading first reported a position in CTSO in Q1 2023 and held it in 1 quarter. The position peaked at $36K in Q1 2023. 58 funds tracked by Wall St. Rank hold CTSO as of Q2 2023.

  • Belvedere Trading reported no remaining Cytosorbents Corp position as of Q2 2023 after selling out during the quarter.
  • Belvedere Trading sold 10,668 Cytosorbents Corp shares in Q2 2023, an estimated $36K.
  • Belvedere Trading first reported a position in Cytosorbents Corp in Q1 2023 and held it in 1 quarter.
  • Belvedere Trading's Cytosorbents Corp position peaked at $36K in Q1 2023.
  • 58 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2023.

Based on Belvedere Trading's 13F filing for Q2 2023, filed 8 Aug 2023.